Abiopharma

🔍 MCCOY JOHN A. JR. (Executive)

Company: ABBOTT LABORATORIES (ABT)

Report Date: 2025-09-01

Detailed Transactions and Holdings:

• Sold 79 shares of Common shares without par value at $132.66 per share (Direct)
  Date: 2025-09-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 20,982.00 | transaction_form_type: 4
• Holds 0 shares of Common shares without par value (Direct)
  Date: 2025-09-01 | Code: H | nature_of_ownership: Profit Sharing Trust | shares_owned_after: 57.00 | Footnotes: F1

Footnotes:

• F1: Balance in the Abbott Laboratories Stock Retirement Trust as of September 1, 2025.